Hong Kong
· Delayed Price · Currency is HKD Beijing Biostar Pharmaceuticals Statistics
Total Valuation
Beijing Biostar Pharmaceuticals has a market cap or net worth of HKD 5.89 billion. The enterprise value is 5.35 billion.
| Market Cap | 5.89B |
| Enterprise Value | 5.35B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Beijing Biostar Pharmaceuticals has 364.59 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 364.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 5.99% |
| Float | 131.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 77.05 |
| PB Ratio | 7.10 |
| P/TBV Ratio | 7.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -25.60 |
| EV / Sales | 72.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -27.40 |
Financial Position
The company has a current ratio of 14.48, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.48 |
| Quick Ratio | 13.53 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -3,797.81 |
Financial Efficiency
Return on equity (ROE) is -23.84% and return on invested capital (ROIC) is -16.98%.
| Return on Equity (ROE) | -23.84% |
| Return on Assets (ROA) | -15.93% |
| Return on Capital (ROIC) | -16.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.68 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 25.11 |
| Average Volume (20 Days) | 349,470 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beijing Biostar Pharmaceuticals had revenue of HKD 73.41 million and -208.93 million in losses. Loss per share was -0.60.
| Revenue | 73.41M |
| Gross Profit | 51.59M |
| Operating Income | -238.48M |
| Pretax Income | -208.93M |
| Net Income | -208.93M |
| EBITDA | -228.38M |
| EBIT | -238.48M |
| Loss Per Share | -0.60 |
Balance Sheet
The company has 634.58 million in cash and 990,404 in debt, giving a net cash position of 633.59 million or 1.74 per share.
| Cash & Cash Equivalents | 634.58M |
| Total Debt | 990,404 |
| Net Cash | 633.59M |
| Net Cash Per Share | 1.74 |
| Equity (Book Value) | 796.69M |
| Book Value Per Share | 2.28 |
| Working Capital | 649.75M |
Cash Flow
In the last 12 months, operating cash flow was -164.51 million and capital expenditures -30.67 million, giving a free cash flow of -195.19 million.
| Operating Cash Flow | -164.51M |
| Capital Expenditures | -30.67M |
| Free Cash Flow | -195.19M |
| FCF Per Share | -0.54 |
Margins
Gross margin is 70.27%, with operating and profit margins of -324.87% and -284.60%.
| Gross Margin | 70.27% |
| Operating Margin | -324.87% |
| Pretax Margin | -284.60% |
| Profit Margin | -284.60% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Beijing Biostar Pharmaceuticals does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |